Učitavanje...
Discovery and validation of new molecular targets in treating dyslipidemia: The role of human genetics
Several high profile failures of lipid-related therapeutics in clinical trials have led to intense interest in improved discovery and preclinical prioritization of potential targets. The careful study of patients with rare monogenic disorders has played a key role in establishing the causal role of...
Spremljeno u:
Glavni autori: | , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
2009
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3328807/ https://ncbi.nlm.nih.gov/pubmed/20211435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tcm.2009.12.003 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|